PURPOSE: Most women are diagnosed with breast cancer when they are of working age. How long are breast cancer patients absent? How many of them return to work? METHODS: ArboNed Occupational Health Services documents sickness absence data of 1 million workers of whom 40% were women. Between 2001 and 2005, 2,259 women had 2,361 episodes of sickness absence due to breast cancer. These absence episodes were followed for 2 years using Kaplan-Meier analysis. RESULTS: The mean +/- standard error of mean duration of absence due to breast cancer was 349 +/- 5 days. Thirty-seven percent of absences lasted longer than one year and 12% of absences lasted longer than 2 years particularly in women aged 25-34 years. CONCLUSIONS: The mean duration of sickness absence due to breast cancer was nearly a year, but most women returned to work. The results of the study can be used as a reference for return to work of women following breast cancer.
PURPOSE: Most women are diagnosed with breast cancer when they are of working age. How long are breast cancerpatients absent? How many of them return to work? METHODS: ArboNed Occupational Health Services documents sickness absence data of 1 million workers of whom 40% were women. Between 2001 and 2005, 2,259 women had 2,361 episodes of sickness absence due to breast cancer. These absence episodes were followed for 2 years using Kaplan-Meier analysis. RESULTS: The mean +/- standard error of mean duration of absence due to breast cancer was 349 +/- 5 days. Thirty-seven percent of absences lasted longer than one year and 12% of absences lasted longer than 2 years particularly in women aged 25-34 years. CONCLUSIONS: The mean duration of sickness absence due to breast cancer was nearly a year, but most women returned to work. The results of the study can be used as a reference for return to work of women following breast cancer.
Authors: Nancy M Nachreiner; Rada K Dagher; Patricia M McGovern; Beth A Baker; Bruce H Alexander; Susan Goodwin Gerberich Journal: AAOHN J Date: 2007-07
Authors: Tyler G Ketterl; Karen L Syrjala; Jacqueline Casillas; Linda A Jacobs; Steven C Palmer; Mary S McCabe; Patricia A Ganz; Linda Overholser; Ann Partridge; Emily Jo Rajotte; Abby R Rosenberg; Betsy Risendal; Donald L Rosenstein; Kevin Scott Baker Journal: Cancer Date: 2019-02-01 Impact factor: 6.860
Authors: M H W Frings-Dresen; A G E M de Boer; A C G N M Zaman; K M A J Tytgat; J H G Klinkenbijl; F C den Boer; M A Brink; J C Brinkhuis; D J Bruinvels; L C M Dol; P van Duijvendijk; P H J Hemmer; B Lamme; O J L Loosveld; M M Mok; T Rejda; H Rutten; A Schoorlemmer; D J Sonneveld; L P S Stassen; R P Veenstra; A van de Ven; E R Velzing Journal: J Occup Rehabil Date: 2021-06
Authors: Corine Tiedtke; Angelique de Rijk; Peter Donceel; Marie-Rose Christiaens; Bernadette Dierckx de Casterlé Journal: BMC Public Health Date: 2012-07-23 Impact factor: 3.295